Q2 2023

Filed Feb 14, 2023 · 10-Q · 45 days after period end · 0000862668-23-000008

Q2 2023 · 10-Q

Revenue

$3.01M

+11.3% vs Q2 2022

Net Income

-$6.04K

N/M vs Q2 2022

EPS Diluted

$0.00

N/M vs Q2 2022

Operating Income$3N/M

Operating Cash Flow

Same quarter

Metric	Q2 2023	Q2 2022	Q2 2021	Q2 2020
Revenue	$3.01M	$2.70M	$2.90M	$2.74M
Net Income	-$6.04K	-$53.15K	$98.48K	-$675.34K
EPS Diluted	$0.00	-$0.01	$0.01	-$0.09

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Escalon Medical Corp · CIK 862668 · Engraved from SEC EDGAR